Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for platelet engraftment after umbilical cord blood transplantation in lysosomal storage diseases
ChiCTR2100047583Phase 4Recruiting
- Sponsor
- Affiliated Children's Hospital, Capital Institute of Pediatrics
- Start
- Jun 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant human thrombopoietin in lysosomal storage disease (LSD), sponsored by Affiliated Children's Hospital, Capital Institute of Pediatrics. Primary endpoint: Platelet quantity. Started Jun 2021; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
lysosomal storage disease (LSD)
Beyond the preview
Go deeper on ChiCTR2100047583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047583.